Literature DB >> 8386915

The wall associated lipoteichoic acid of Streptococcus sanguis.

S D Hogg1, L A Old.   

Abstract

A competitive ELISA is described for the measurement of lipoteichoic acid. The assay was used to determine the wall associated lipoteichoic acid of Streptococcus sanguis which was found to represent only 2-4% of the phenol extractable content. Extracellular lipoteichoic acid was detected even after exhaustive cell washing. This material was not the result of de novo synthesis because membrane de-polarization had no effect on the amount detected. Since extracellular lipoteichoic acid interfered with the measurement of cell surface antigen, cells were fixed with glutaraldehyde prior to assay. Lipoteichoic acid was demonstrated on the surface of fixed cells which did not leak antigen. The relevance of fixation used in antigen location studies by electron microscopy of immune-labelled cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386915     DOI: 10.1007/bf00871728

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  25 in total

Review 1.  Atypical lipoteichoic acids of gram-positive bacteria.

Authors:  I C Sutcliffe; N Shaw
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

2.  Electron microscopic demonstration of carbohydrates and lipoteichoic acid in cell envelopes of streptococci by lectins labelled with ferritin or gold.

Authors:  M Wagner; B Wagner
Journal:  Acta Histochem Suppl       Date:  1988

3.  High amounts of lipoteichoic acid in sucrose-induced plaque in vivo.

Authors:  G Rølla; R V Oppermann; W H Bowen; J E Ciardi; K W Knox
Journal:  Caries Res       Date:  1980       Impact factor: 4.056

4.  Effect of carbohydrate source and growth conditions on the production of lipoteichoic acid by Streptococcus mutans Ingbritt.

Authors:  N A Jacques; L Hardy; L K Campbell; K W Knox; J D Evans; A J Wicken
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor.

Authors:  E H Beachey; W A Simpson
Journal:  Infection       Date:  1982       Impact factor: 3.553

6.  Effect of growth conditions on the formation of extracellular lipoteichoic acid by Streptococcus mutans BHT.

Authors:  N A Jacques; L Hardy; K W Knox; A J Wicken
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

7.  Electron microscopic localization of lipoteichoic acid on group A streptococci.

Authors:  M Rýc; B Wagner; M Wagner; R Bicová
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-08

8.  Production of lipoteichoic acid by lactobacilli and streptococci grown in different environments.

Authors:  A J Wicken; K W Broady; A Ayres; K W Knox
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.

Authors:  H Hanberger; L E Nilsson; R Maller; B Isaksson
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Immunoperoxidase and electron microscopy studies of staphylococcal lipoteichoic acid.

Authors:  P Aasjord; A Grov
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-02
View more
  2 in total

1.  The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.

Authors:  Thomas A Penfound; Itzhak Ofek; Harry S Courtney; David L Hasty; James B Dale
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

2.  Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes.

Authors:  Harry S Courtney; Itzhak Ofek; Thomas Penfound; Victor Nizet; Morgan A Pence; Bernd Kreikemeyer; Andreas Podbielski; Andreas Podbielbski; David L Hasty; James B Dale
Journal:  PLoS One       Date:  2009-01-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.